Your browser doesn't support javascript.
loading
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Marks, Zoe R C; Campbell, Nicole K; Mangan, Niamh E; Vandenberg, Cassandra J; Gearing, Linden J; Matthews, Antony Y; Gould, Jodee A; Tate, Michelle D; Wray-McCann, Georgie; Ying, Le; Rosli, Sarah; Brockwell, Natasha; Parker, Belinda S; Lim, San S; Bilandzic, Maree; Christie, Elizabeth L; Stephens, Andrew N; de Geus, Eveline; Wakefield, Matthew J; Ho, Gwo-Yaw; McNally, Orla; McNeish, Iain A; Bowtell, David D L; de Weerd, Nicole A; Scott, Clare L; Bourke, Nollaig M; Hertzog, Paul J.
Afiliação
  • Marks ZRC; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Campbell NK; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Mangan NE; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Vandenberg CJ; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Gearing LJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Matthews AY; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Gould JA; Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Tate MD; Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.
  • Wray-McCann G; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Ying L; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Rosli S; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Brockwell N; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Parker BS; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Lim SS; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Bilandzic M; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Christie EL; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Stephens AN; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • de Geus E; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Wakefield MJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Ho GY; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • McNally O; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • McNeish IA; Research Division, Peter McCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Bowtell DDL; Research Division, Peter McCallum Cancer Centre, Melbourne, Victoria, Australia.
  • de Weerd NA; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Scott CL; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Bourke NM; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia.
  • Hertzog PJ; Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Nature ; 620(7976): 1063-1070, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37587335
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Interferon Tipo I / Proteínas Supressoras de Tumor Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Interferon Tipo I / Proteínas Supressoras de Tumor Idioma: En Ano de publicação: 2023 Tipo de documento: Article